- Expanded indications likely for apremilast: https://bit.ly/3lx1zTZ
- Neoadjuvant immunotherapy combo produces high response rate in melanoma: https://bit.ly/33Dx0Wr
- Blood glucose on admission predicts COVID-19 severity in all: https://bit.ly/39yJjXS
* * *
Advances in noninvasive skin imaging present new opportunities for inclusion and equitable treatment of patients with skin of color. In this episode, Candrice R. Heath, MD (@DrCandriceHeath), talks to Josèe Smith and Steven Daveluy, MD, about the use of optical coherence tomography (OCT) to establish a baseline for all skin types can improve how dermatologists process pathology in the skin. They review various factors that influence OCT results and how results differ based on Fitzpatrick skin type, age, and level of sun exposure. They also highlight the benefits of noninvasive imaging versus biopsy in clinical practice. “[Even] though skin cancer is less common in skin of color, we know that melanoma and other types of skin cancer are usually diagnosed at later stages and more complicated stages, and so having earlier ways of detecting skin cancer in skin of color I think is really important for the future,” Ms. Smith explains.
Ms. Smith and Dr. Daveluy’s poster from the Skin of Color Society (@SkinOfColor) Scientific Symposium won the Crowd Favorite award.
* * *
Hosts: Nick Andrews; Candrice R. Heath, MD (Temple University Hospital, Philadelphia, Pennsylvania)
Guests: Josèe Smith, BS (Wayne State University, Detroit); Steven Daveluy, MD (Wayne State University and Wayne County Medical Society of Southeast Michigan, Detroit)
Disclosures: Dr. Heath, Ms. Smith, and Dr. Daveluy report no conflicts of interest.
Show notes by: Alicia Sonners, Melissa Sears
* * *
You can find more of our podcasts at http://www.mdedge.com/podcasts
Email the show: email@example.com
Interact with us on Twitter: @MDedgeDerm